The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

In patients with fibromyalgia, a 24-week treatment with a 50-mg/d dose of plant-derived cannabidiol did not outperform placebo in terms of pain relief or health-related quality of life. The only ...

SOLON, Ohio--(BUSINESS WIRE)--Pioneering the frontier of super-pulsed laser technology, Multi Radiance Medical highlights the impact of FibroLux Therapeutic Laser, one of the first and only ...

Pregabalin, known to many by its trade name, “Lyrica,” works well, when, well, it works. A recent review of clinical studies involving Lyrica for the treatment of fibromyalgia concluded that only a ...

People who are suffering from fibromyalgia pain but don’t want to risk addiction to an opioid are closer to a new option for treatment. Tonix Pharmaceuticals TNXP reported positive Phase 3 study ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp.

UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...

Terpenes from the Cannabis sativa plant may be a viable medication for fibromyalgia and post-surgical pain relief, according ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations ...

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...